Veraxa Biotech Holding AG Cash Flow Statement (2025) | VRXA

Cash Flow Statement Dec2025
Operating Activities
Cash from Operations (Quarter) 1,251.17
Change in Working Capital
Change in Accured Expenses (Quarter) 22,521.06
Financing Activities
Cash from Financing Activities (Quarter) 125,116.98
Additional items
Change in Cash (Quarter) 126,368.15
Free Cash Flow (Quarter) 1,251.17
Net Cash Flow (Quarter) 126,368.15